This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Join Skadden at EU Pharmaceutical Law Forum 2020

The traits that fueled Skadden’s rise from a New York start-up to a global powerhouse — collaborative, innovative, persistent — continue to define our firm culture. We remain intensely focused on the simple formula of developing an inclusive complement of extraordinary attorneys, working together as a team to deliver the highest quality legal work.

Connect with us at EU Pharmaceutical Law Forum and discover how we can help your company.

Looking for Solutions?

Skadden counsels health care and life sciences clients in the areas of transactional, litigation and enforcement, regulatory, finance and intellectual property matters. We represent companies and investors around the globe in every sector of the industry, including pharmaceutical, biotechnology and medical device companies; hospital and health care systems; long-term care facilities; and other service providers. We work with clients on matters of all sizes, from the largest mergers in the industry to smaller, early-stage transactions.


We offer a full-range of services, including advising on M&A, corporate restructurings, financings, private equity, complex licensing transactions, product liability defenses, intellectual property matters, regulatory counseling, global and U.S. investigations and enforcement, antitrust matters, securities litigation matters and related legal services.

Our global footprint with 22 offices in the Americas, Europe and Asia Pacific allows our attorneys to work seamlessly across our corporate, litigation and regulatory practices to provide service that balances the business prerogatives of our clients with the legal demands on the industry

Our extensive work in health care provides our attorneys with current, sector-specific insights that make our legal advice timely and relevant in the fast-moving health care and life sciences industries.

Come Along to Our Session!


INTERACTIVE DISCUSSION FORUM: Excessive Pricing in the Pharmaceutical Industry
INTERACTIVE DISCUSSION FORUM: Excessive Pricing in the Pharmaceutical Industry
Learn More

Thought Leadership from Skadden


May 2020
Impact of COVID-19 on antitrust  in the Pharmaceutical sector:  Top compliance tips
May 2020
Read More
June 2020
Investment in Possible Future Generic Marketing Excludes Legitimate Basis for Pharma Settlement, Suggest EU Advocate General
June 2020
Read More
March 2020
The UK Court of Appeal Overturns CAT and Imposes Agency Discretion on Excessive Price Benchmark
March 2020
Read More